CH646604A5 - Composition pharmaceutique a effet prolonge et son procede de fabrication. - Google Patents
Composition pharmaceutique a effet prolonge et son procede de fabrication. Download PDFInfo
- Publication number
- CH646604A5 CH646604A5 CH9281A CH9281A CH646604A5 CH 646604 A5 CH646604 A5 CH 646604A5 CH 9281 A CH9281 A CH 9281A CH 9281 A CH9281 A CH 9281A CH 646604 A5 CH646604 A5 CH 646604A5
- Authority
- CH
- Switzerland
- Prior art keywords
- agent
- release
- composition according
- tablets
- amount
- Prior art date
Links
- 0 CC(C(C(C(*)*C(F)(F)F)I)N)O Chemical compound CC(C(C(C(*)*C(F)(F)F)I)N)O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11143080A | 1980-01-11 | 1980-01-11 | |
| US06/194,453 US4308251A (en) | 1980-01-11 | 1980-10-17 | Controlled release formulations of orally-active medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH646604A5 true CH646604A5 (fr) | 1984-12-14 |
Family
ID=26808896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH9281A CH646604A5 (fr) | 1980-01-11 | 1981-01-08 | Composition pharmaceutique a effet prolonge et son procede de fabrication. |
Country Status (22)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2496082A (en) * | 1947-05-24 | 1950-01-31 | Ashenfelter William | Scaffold structure |
| IT1144911B (it) * | 1981-03-19 | 1986-10-29 | Pharmatec Spa | Composizione farmaceutica a rilascio controllato contenente ibuprofen |
| JPS59227817A (ja) * | 1983-06-07 | 1984-12-21 | Toyo Jozo Co Ltd | 持続性経口用ブレデニン製剤 |
| JPH0662404B2 (ja) * | 1983-06-14 | 1994-08-17 | シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド | 制御放出性ナプロキセンおよびナプロキセンナトリウム錠 |
| ZA836030B (en) * | 1983-08-16 | 1985-02-27 | Verex Lab | Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions |
| ZA836031B (en) * | 1983-08-16 | 1985-02-27 | Verex Lab | Constant release rate solid dosage theophylline formulation |
| US5385738A (en) * | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
| US4855134A (en) * | 1983-10-14 | 1989-08-08 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release preparation |
| US4774091A (en) * | 1983-10-14 | 1988-09-27 | Sumitomo Pharmaceuticals Company, Ltd. | Long-term sustained-release preparation |
| DE3486029T2 (de) * | 1983-10-14 | 1993-05-13 | Sumitomo Pharma | Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung. |
| ES2054613T3 (es) * | 1985-12-27 | 1994-08-16 | Sumitomo Pharma | Un metodo para preparar una formulacion de liberacion mantenida. |
| GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
| US4968508A (en) * | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
| ZA881301B (en) * | 1987-02-27 | 1989-10-25 | Lilly Co Eli | Sustained release matrix formulations |
| AU6403196A (en) | 1995-06-30 | 1997-02-05 | Baylor University | Polyester/carboxylic acid composite materials |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2953497A (en) * | 1953-06-03 | 1960-09-20 | Howard A Press | Therapeutic tablets |
| NL128902C (US06653308-20031125-C00199.png) * | 1960-06-06 | |||
| US3577514A (en) * | 1968-06-10 | 1971-05-04 | Pfizer | Sustained release pharmaceutical tablets |
| US3773920A (en) * | 1971-07-14 | 1973-11-20 | Nikken Chemicals Co Ltd | Sustained release medicinal composition |
| US3906086A (en) * | 1971-07-19 | 1975-09-16 | Richard G Powers | Timed-release aspirin |
| GB1500300A (en) * | 1975-01-06 | 1978-02-08 | Ciba Geigy Ag | Pharmaceutical preparation for the treatment of circulatory disorders |
| JPS5411226A (en) * | 1977-06-24 | 1979-01-27 | Shin Etsu Chem Co Ltd | Disintegratable granule |
-
1980
- 1980-12-23 NZ NZ195933A patent/NZ195933A/xx unknown
- 1980-12-23 IN IN1418/CAL/80A patent/IN151913B/en unknown
-
1981
- 1981-01-05 AU AU65976/81A patent/AU542824B2/en not_active Ceased
- 1981-01-06 FR FR8100087A patent/FR2473308B1/fr not_active Expired
- 1981-01-07 NL NL8100037A patent/NL8100037A/nl not_active Application Discontinuation
- 1981-01-07 DE DE19813100191 patent/DE3100191A1/de active Granted
- 1981-01-08 CH CH9281A patent/CH646604A5/fr not_active IP Right Cessation
- 1981-01-08 JP JP157881A patent/JPS56103110A/ja active Pending
- 1981-01-08 DK DK6181A patent/DK6181A/da not_active Application Discontinuation
- 1981-01-08 BE BE0/203426A patent/BE886998A/fr unknown
- 1981-01-08 GB GB8100522A patent/GB2067072B/en not_active Expired
- 1981-01-08 ES ES498369A patent/ES8205353A1/es not_active Expired
- 1981-01-09 GR GR63828A patent/GR73843B/el unknown
- 1981-01-09 SE SE8100104A patent/SE447450B/sv not_active IP Right Cessation
- 1981-01-09 IT IT47537/81A patent/IT1221041B/it active
- 1981-01-09 CA CA000368219A patent/CA1140466A/en not_active Expired
- 1981-01-09 IE IE36/81A patent/IE50806B1/en unknown
- 1981-01-09 FI FI810056A patent/FI76927C/fi not_active IP Right Cessation
- 1981-01-09 NO NO810062A patent/NO156153C/no unknown
- 1981-01-09 AT AT0005481A patent/AT374681B/de not_active IP Right Cessation
- 1981-01-09 LU LU83052A patent/LU83052A1/fr unknown
- 1981-01-09 ZA ZA00810136A patent/ZA81136B/xx unknown
-
1982
- 1982-01-29 ES ES509179A patent/ES509179A0/es active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0287488B1 (fr) | Médicament, produit diététique et produit d'hygiène sous la forme d'une composition pulvérulente obtenue par adsorption de principes actifs sur un sucre à dissolution rapide et procédé d'obtention de ladite composition | |
| CH646604A5 (fr) | Composition pharmaceutique a effet prolonge et son procede de fabrication. | |
| US4308251A (en) | Controlled release formulations of orally-active medicaments | |
| WO2010055260A1 (fr) | Nouvelle composition à base d'acide gamma-hydroxybutyrique | |
| FR2602423A1 (fr) | Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede | |
| WO1982001649A1 (fr) | Nouvelle forme galenique du fenofibrate, son procede d'obtention, son application comme medicament | |
| JPH0122245B2 (US06653308-20031125-C00199.png) | ||
| JP2003055203A (ja) | ユビキノン含有製剤 | |
| CH647676A5 (fr) | Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation. | |
| JPS63107917A (ja) | イブプロフエン徐放性製剤およびその製造方法 | |
| MX2007016072A (es) | Formulaciones de diclofenac y metodos para usarlas. | |
| HU198621B (en) | Process for producing easily administrable pharmaceutical compositions comprising antibacterial active ingredient, with regulated release of active ingredient | |
| FR2541287A1 (fr) | Preparation stable administrable par voie orale de macrolides antibiotiques et procede pour les stabiliser | |
| FR2524314A1 (fr) | Medicament a action salidiuretique, contenant des dihydropyridines | |
| FR2529784A1 (fr) | Medicament a liberation retardee contenant du 1-(p-(isopropylthio)-phenyl)-2-octylamino-1-propanol | |
| JP2004507479A (ja) | 粒状化可能な混合物の調製方法及びカルニチン・マグネシウム・ヒドロキシクエン酸塩 | |
| AU2003235700B2 (en) | Stable salts of o-acetylsalicylic acid containing basic amino acids II | |
| CA2354574C (fr) | Troxerutine a forte teneur en trihydroxy-ethyl-rutoside et procede de preparation | |
| FR2467596A1 (fr) | Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action | |
| EP0483320B1 (fr) | Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation | |
| JPH02206A (ja) | エキシホンと水溶性高分子化合物とを含有することを特徴とする新規製剤 | |
| JPH11322584A (ja) | ベザフィブラート徐放性製剤 | |
| LU87777A1 (fr) | Nouvelle forme galenique orale ameliorant la biodisponibilite | |
| RU2233155C1 (ru) | Способ получения витаминного комплекса в виде драже | |
| CA2182024C (fr) | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |